PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Managing BRCA Mutation Carriers10.1007/978-3-319-59198-8_82017135-150Medical Management of Breast Cancer in BRCA Mutation CarriersSoley Bayraktar, Banu K. Arunhttp://link.springer.com/content/pdf/10.1007/978-3-319-59198-8_8
Managing BRCA Mutation Carriers10.1007/978-3-319-59198-8_72017119-134Surgical Management of Breast Cancer in BRCA Mutation CarriersPatricia A. Cronin, Hiram S. Codyhttp://link.springer.com/content/pdf/10.1007/978-3-319-59198-8_7
The Breast10.1016/s0960-9776(19)30087-6201944S9Is prophylactic mastectomy justified in women without BRCA mutation?E. Rutgershttps://api.elsevier.com/content/article/PII:S0960977619300876?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0960977619300876?httpAccept=text/plain
The Breast10.1016/s0960-9776(19)31126-9201948S62-S64Is prophylactic mastectomy justified in women without BRCA mutation?Emiel J.T. Rutgershttps://api.elsevier.com/content/article/PII:S0960977619311269?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0960977619311269?httpAccept=text/plain
Managing BRCA Mutation Carriers10.1007/978-3-319-59198-8_92017151-170Radiation Oncology Considerations in the Management of Mutation Carriers with Breast CancerMeena S. Moranhttp://link.springer.com/content/pdf/10.1007/978-3-319-59198-8_9
The Breast10.1016/s0960-9776(17)30164-9201732S44-S45Whole exome sequencing revealed a novel 1-bp PALB2 deletion mutation (D434fs) in a breast cancer patient with a BRCA1 variant of uncertain clinical significance.A. Peeters, C. Van Heerden, M. Kotzehttps://api.elsevier.com/content/article/PII:S0960977617301649?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0960977617301649?httpAccept=text/plain
Human Mutation10.1002/humu.221942013349iv-ivWhole Exome Sequencing to Map the Genomic Evolution of Metastatic Prostate CancerTerence Friedlanderhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhumu.22194, http://onlinelibrary.wiley.com/wol1/doi/10.1002/humu.22194/fullpdf
Breast Cancer Research and Treatment10.1007/s10549-012-2158-620121352355-366Systemic therapy options in BRCA mutation-associated breast cancerSoley Bayraktar, Stefan Glückhttp://link.springer.com/content/pdf/10.1007/s10549-012-2158-6.pdf, http://link.springer.com/article/10.1007/s10549-012-2158-6/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10549-012-2158-6
Breast Cancer Research and Treatment10.1007/s10549-014-2902-120141443607-614The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutationPål Møller, Astrid Stormorken, Marit Muri Holmen, Anne Irene Hagen, Anita Vabø, Lovise Mæhlehttp://link.springer.com/content/pdf/10.1007/s10549-014-2902-1.pdf, http://link.springer.com/article/10.1007/s10549-014-2902-1/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10549-014-2902-1
The Lancet Oncology10.1016/s1470-2045(07)70348-020078121042-1043Breast-cancer risk in BRCA -mutation-negative women from BRCA -mutation-positive familiesHormuzd A Katki, Mitchell H Gail, Mark H Greenehttps://api.elsevier.com/content/article/PII:S1470204507703480?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1470204507703480?httpAccept=text/plain